- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tevogen Inc (TVGN)
Tevogen Inc stock price live, this page displays NASDAQ TVGN stock exchange data. View the TVGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tevogen Inc real time stock price chart below.
What Is the Tevogen Inc Stock Price Today?
The Tevogen Inc stock price today is 6.461.
What Is the Stock Symbol for Tevogen Inc?
The stock symbol for Tevogen Inc is "TVGN."
What Stock Exchange Does Tevogen Inc Trade On?
Tevogen Inc is listed and trades on the NASDAQ stock exchange.
Is Tevogen Inc a Good Stock to Buy?
Determining whether Tevogen Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TVGN quote. (ISIN: US88165K2006)
What Is the Tevogen Inc Stock Price Today?
The Tevogen Inc stock price today is 6.461.
What Is the Stock Symbol for Tevogen Inc?
The stock symbol for Tevogen Inc is "TVGN."
What Stock Exchange Does Tevogen Inc Trade On?
Tevogen Inc is listed and trades on the NASDAQ stock exchange.
Is Tevogen Inc a Good Stock to Buy?
Determining whether Tevogen Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TVGN quote. (ISIN: US88165K2006)
6.461
-0.139(-2.11%)
Real-time Data·
Fair Value
An estimate of a Tevogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.461
6.520
52 wk Range
3.636
39.000
TVGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Tevogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.4616.520
52 wk Range
3.63639.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TVGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tevogen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Form 4 Tevogen Bio Holdings Inc For: 10 July- Investing.com
Form 8K Tevogen Bio Holdings Inc For: 10 September- Investing.com
Form 4 Tevogen Bio Holdings Inc For: 10 July- Investing.com
Form DEF 14A Tevogen Inc. For: 3 August- Investing.com
- Form 8K Tevogen Bio Holdings Inc For: 10 September
- Investing.com
- Form DEF 14A Tevogen Inc. For: 3 August
- Investing.com
Form PRE 14A Tevogen Bio Holdings Inc. For: 23 July- Investing.com
Form 13D/A Tevogen Bio Holdings Inc. For: 14 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-1.52 / --
Revenue / Forecast
-- / --
Compare TVGN to Peers and Sector
Metrics to compare | TVGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTVGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.7x | −2.7x | −0.3x | |
PEG Ratio | −0.12 | −0.07 | 0.00 | |
Price/Book | −5.9x | 2.8x | 2.6x | |
Price / LTM Sales | - | 66.9x | 3.0x | |
Upside (Analyst Target) | - | 285.5% | 58.5% | |
Fair Value Upside | Unlock | 17.0% | 7.1% | Unlock |
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tevogen (TVGN) Stock Price Today?
The Tevogen stock price today is 6.461 USD.
What Stock Exchange Does Tevogen Trade On?
Tevogen is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tevogen?
The stock symbol for Tevogen is "TVGN."
What Is the Tevogen Market Cap?
As of today, Tevogen market cap is 103.860M USD.
What Is Tevogen's Earnings Per Share (TTM)?
The Tevogen EPS (TTM) is -6.321.
From a Technical Analysis Perspective, Is TVGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tevogen Stock Split?
Tevogen has split 1 times.
What is the current trading status of Tevogen (TVGN)?
As of Oct 06, 2026, Tevogen (TVGN) is trading at a price of 6.461 USD, with a previous close of 6.600 USD. The stock has fluctuated within a day range of 6.461 USD to 6.520 USD, while its 52-week range spans from 3.636 USD to 39.000 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.